Humira: Early Response, Future Success
Doctors want to know if the drugs they prescribe to their ankylosing spondylitis patients are helping. If they are not seeing positive results, they may want to change course as soon as possible.
New Psoriasis Hope
For those without psoriasis, the common autoimmune condition that generally manifests as raised red skin with silver-white patches of dead skin, the condition may appear to be just a minor cosmetic annoyance.
Dimming the Flame of Pain: Arthritis and All That
Your joints may feel tight. Your hips might hurt so bad that you can barely walk. Your back may feel so weak that you cannot even sit up straight. If you are experiencing these symptoms, you might have arthritis.
Abbott Drug Gets Positive Review in Ulcerative Colitis
Abbott announced that the European Committee for Medicinal Products for Human Use ( CHMP ) has issued a positive opinion for Humira ( adalimumab ) in adults with moderate to severely active ulcerative colitis ( UC ) who have not responded to, cannot tolerate or have medical contraindications to conventional therapies.
No Doubt About Arthritis Drug's Benefit
A few years ago, the FDA warned that certain drugs may raise the risk of cancer in children with juvenile arthritis. While it still seems these children are more prone to cancer, the drugs might not be to blame.
A Pain in the Back
Arthritis comes in many forms. One of these may have a funny sounding name, but the pain it brings is no laughing matter. It is called ankylosing spondylitis , and it is a pain in the back.
Psoriasis: Don't Hide From Help
As a child, Alisha B. had a few patches of what looked like a rash on her knees and elbows. She and her parents didn't think anything of it. Then things changed, and her skin has ever been the same since.
The RA Heart Left Unprotected
The inflammation of rheumatoid arthritis can affect more than the joints; it also poses a threat to the heart. When it comes to protecting the heart health of rheumatoid arthritis patients, certain drugs are falling short.
FDA Focus on TNF Blockers
A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.
Advancing Crohn's Disease Treatment
Even 15 or 20 years ago hearing a diagnosis of Crohn's disease was bad news. Advances in treatment now mean that the disease is manageable and patients can live a normal life. It's no longer the death sentence it once was.